4'-Bromo-2,2,2-trifluoroacetophenone, 97%
4'-Bromo-2,2,2-trifluoroacetophenone, 97%
4'-Bromo-2,2,2-trifluoroacetophenone, 97%
4'-Bromo-2,2,2-trifluoroacetophenone, 97%
Thermo Scientific Chemicals

4'-Bromo-2,2,2-trifluoroacetophenone, 97%

CAS: 16184-89-7 | C8H4BrF3O | 253.018 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
Catalog number H33627.03
also known as H33627-03
Price (EUR)
131,00
Each
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (EUR)
131,00
Each
Add to cart
Chemical Identifiers
CAS16184-89-7
IUPAC Name1-(4-bromophenyl)-2,2,2-trifluoroethan-1-one
Molecular FormulaC8H4BrF3O
InChI KeyIHGSAQHSAGRWNI-UHFFFAOYSA-N
SMILESFC(F)(F)C(=O)C1=CC=C(Br)C=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)White to pale yellow or clear colorless to pale yellow
FormCrystals or powder or crystalline powder or fused solid or liquid as melt
Assay (GC)≥96.0%
Melting Point (clear melt)26.0-32.0°C
Proton NMRConforms to structure
4?-Bromo-2,2,2-trifluoroacetophenone may be used in the preparation of carbonyl-bridged bithiazole derivatives. Also used as a reagent to synthesize MK-5046, a selective Bombesin receptor subtype-3 agonist used to treat obesity.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4′-Bromo-2,2,2-trifluoroacetophenone may be used in the preparation of carbonyl-bridged bithiazole derivatives. Also used as a reagent to synthesize MK-5046, a selective Bombesin receptor subtype-3 agonist used to treat obesity.

Solubility
Slightly soluble in water.

Notes
Moisture Sensitive. Store away from water/moisture. Store away from oxidizing agent.
RUO – Research Use Only

General References:

  1. Ie Y, et al. Air-Stable n-Type Organic Field-Effect Transistors Based on Carbonyl-Bridged Bithiazole Derivatives. Adv. Funct. Mater. 201020 (6), 907-13.
  2. Iyassu K. Sebhat; Christopher Franklin; Michael M.-C. Lo; David Chen; James P. Jewell; Randy Miller; Jianmei Pang; Oksana Palyha; Yanqing Kan; Theresa M. Kelly; Xiao-Ming Guan; Donald J. Marsh; Jennifer A. Kosinski; Joseph M. Metzger; Kathryn Lyons; Jasminka Dragovic; Peter R. Guzzo; Alan J. Henderson; Marc L. Reitman; Ravi P. Nargund; Matthew J. Wyvratt; and Linus S. Lin. Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity. ACS Med. Chem. Lett. 20112 (1), 43-47.